165 related articles for article (PubMed ID: 2553849)
1. Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells.
Tamm I; Cardinale I; Krueger J; Murphy JS; May LT; Sehgal PB
J Exp Med; 1989 Nov; 170(5):1649-69. PubMed ID: 2553849
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 enhances motility of breast carcinoma cells.
Sehgal PB; Tamm I
EXS; 1991; 59():178-93. PubMed ID: 1655518
[TBL] [Abstract][Full Text] [Related]
3. Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis.
Tamm I; Cardinale I; Murphy JS
Proc Natl Acad Sci U S A; 1991 May; 88(10):4414-8. PubMed ID: 1852008
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 enhances motility of breast cancer cells.
Sehgal PB; Tamm I
Cancer Invest; 1990; 8(6):661-3. PubMed ID: 1963346
[No Abstract] [Full Text] [Related]
5. Interleukin-6 and 12-O-tetradecanoyl phorbol-13-acetate act synergistically in inducing cell-cell separation and migration of human breast carcinoma cells.
Tamm I; Cardinale I; Sehgal PB
Cytokine; 1991 May; 3(3):212-23. PubMed ID: 1653054
[TBL] [Abstract][Full Text] [Related]
6. Cell-adhesion-disrupting action of interleukin 6 in human ductal breast carcinoma cells.
Tamm I; Kikuchi T; Cardinale I; Krueger JG
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3329-33. PubMed ID: 7512730
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells.
Tamm I; Cardinale I; Kikuchi T; Krueger JG
Proc Natl Acad Sci U S A; 1994 May; 91(10):4338-42. PubMed ID: 8183909
[TBL] [Abstract][Full Text] [Related]
8. The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer.
Asgeirsson KS; Olafsdóttir K; Jónasson JG; Ogmundsdóttir HM
Cytokine; 1998 Sep; 10(9):720-8. PubMed ID: 9770334
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 is a motility factor for human breast carcinoma cells in vitro: additive effect with interleukin-6.
Verhasselt B; Van Damme J; van Larebeke N; Put W; Bracke M; De Potter C; Mareel M
Eur J Cell Biol; 1992 Dec; 59(2):449-57. PubMed ID: 1493810
[TBL] [Abstract][Full Text] [Related]
10. IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression.
Kim HS; Jung M; Choi SK; Woo J; Piao YJ; Hwang EH; Kim H; Kim SJ; Moon WK
J Exp Clin Cancer Res; 2018 Aug; 37(1):200. PubMed ID: 30134951
[TBL] [Abstract][Full Text] [Related]
11. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of interleukin-6 in epithelial cells.
Krueger J; Ray A; Tamm I; Sehgal PB
J Cell Biochem; 1991 Apr; 45(4):327-34. PubMed ID: 2045425
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
14. IL-6 receptors and sensitivity to growth inhibition by IL-6 in clones of human breast carcinoma cells.
Chen L; Shulman LM; Revel M
J Biol Regul Homeost Agents; 1991; 5(4):125-36. PubMed ID: 1803860
[TBL] [Abstract][Full Text] [Related]
15. Adhesion, growth and cytoskeletal characteristics of 8701-BC breast carcinoma cells cultured in the presence of type V collagen.
Luparello C; Schillaci R; Pucci-Minafra I; Minafra S
Eur J Cancer; 1990 Mar; 26(3):231-40. PubMed ID: 2162687
[TBL] [Abstract][Full Text] [Related]
16. Modelling the early growth of ductal carcinoma in situ of the breast.
Franks SJ; Byrne HM; King JR; Underwood JC; Lewis CE
J Math Biol; 2003 Nov; 47(5):424-52. PubMed ID: 14605857
[TBL] [Abstract][Full Text] [Related]
17. Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration.
Osuala KO; Sameni M; Shah S; Aggarwal N; Simonait ML; Franco OE; Hong Y; Hayward SW; Behbod F; Mattingly RR; Sloane BF
BMC Cancer; 2015 Aug; 15():584. PubMed ID: 26268945
[TBL] [Abstract][Full Text] [Related]
18. Intracellular FGF-2 promotes differentiation in T-47D breast cancer cells.
Korah RM; Sysounthone V; Scheff E; Wieder R
Biochem Biophys Res Commun; 2000 Oct; 277(1):255-60. PubMed ID: 11027671
[TBL] [Abstract][Full Text] [Related]
19. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB
BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211
[TBL] [Abstract][Full Text] [Related]
20. Growth-stimulating activity of interleukin 6 on human mammary epithelial cells transfected with the int-2 gene.
Basolo F; Calvo S; Fiore L; Conaldi PG; Falcone V; Toniolo A
Cancer Res; 1993 Jul; 53(13):2957-60. PubMed ID: 8100482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
